Drug Shortage Report for KENALOG-40 INJECTION 40MG/ML

Last updated on 2022-08-05 History
Report ID 166071
Drug Identification Number 01999869
Brand name KENALOG-40 INJECTION 40MG/ML
Common or Proper name Triamcinolone Acetonide
Company Name BRISTOL-MYERS SQUIBB CANADA
Market Status MARKETED
Active Ingredient(s) TRIAMCINOLONE ACETONIDE
Strength(s) 40MG
Dosage form(s) SUSPENSION
Route of administration INTRAMUSCULAR INTRA-ARTICULAR INTRAMUSCULAR INTRA-ARTICULAR
Packaging size 5mL
ATC code H02AB
ATC description CORTICOSTEROIDS FOR SYSTEMIC USE, PLAIN
Reason for shortage Demand increase for the drug.
Anticipated start date 2022-08-04
Actual start date
Estimated end date Unknown
Actual end date
Shortage status Actual shortage
Updated date 2022-08-05
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 2344 BOUL. ALFRED-NOBEL, SUITE 300
ST-LAURENT, QUEBEC
CANADA H4S 0A4
Company contact information For more information please contact the Customer Service Desk at 1-800-267-0005

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v4 2022-08-05 English Compare
v3 2022-08-04 French Compare
v2 2022-08-04 English Compare
v1 2022-08-04 English Compare

Showing 1 to 4 of 4